1). According to Paul Hallen, global head of Alcon’s surgical retina and glaucoma franchises, “the NGENUITY 3D Visualization System defines a new standard in ophthalmic visualization.
Analyst David Saxon from Needham maintained a Buy rating on Alcon (ALC – Research Report) and decreased the price target to $106.00 from ...
About Alcon Alcon helps people see brilliantly ... countries each year living with conditions like cataracts, glaucoma, retinal diseases and refractive errors. Our more than 25,000 associates ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback